Atrium Therapeutics receives $15 million milestone from Bristol Myers Squibb
Go back to Atrium Therapeutics receives $15 million milestone from Bristol Myers Squibb| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 67.32 +0.04 (0.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.28 | 52 Week High | $77.12 | |||
| Open | $66.42 | 52 Week Low | $49.03 | |||
| Day High | $67.44 | P/E | 43.71 | |||
| Day Low | $66.42 | EPS | $1.54 | |||
| Volume | 216,061 | |||||
| PROSENSA HOLD (NASDAQ: RNA) | Delayed: 13.58 -0.04 (0.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.62 | 52 Week High | $22.80 | |||
| Open | $13.72 | 52 Week Low | $4.12 | |||
| Day High | $13.72 | P/E | N/A | |||
| Day Low | $13.41 | EPS | $0.00 | |||
| Volume | 5,960 | |||||
